Stay updated on SPX-101 Inhalation Solution in CF Clinical Trial
Sign up to get notified when there's something new on the SPX-101 Inhalation Solution in CF Clinical Trial page.

Latest updates to the SPX-101 Inhalation Solution in CF Clinical Trial page
- Check6 days agoChange DetectedAdded a top-level 'Locations' section with regional site entries (Alberta, Ontario, Auvergne-Rhône-Alpes, Brittany Region, Haute-Normandie, Languedoc-Roussillon, Pays de la Loire Region, Provence-Alpes-Côte d'Azur Region) and removed the corresponding 'Region Locations' subsections for these regions.SummaryDifference0.9%

- Check13 days agoNo Change Detected
- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedRevision: v3.3.2 is a minor UI/version update with no impact on study content; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check35 days agoChange DetectedThe site revision has been updated from v3.2.0 to v3.3.1. There is no change to study content or page intent on the Study Details page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check42 days agoChange DetectedDeleted the government funding lapse notice that warned users about potential data not being up to date and operating status. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check56 days agoChange DetectedThe core study details and endpoints are unchanged; only cosmetic layout adjustments are visible. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check85 days agoChange DetectedUpdate: region name changed to Auvergne-Rhône-Alpes with Pierre-Bénite in that region; software revision bumped from v3.1.0 to v3.2.0; an NIH operating-status notice added.SummaryDifference12%

Stay in the know with updates to SPX-101 Inhalation Solution in CF Clinical Trial
Enter your email address, and we'll notify you when there's something new on the SPX-101 Inhalation Solution in CF Clinical Trial page.